LSD1 inhibitor

This page covers all LSD1 inhibitor drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting LSD1 (lysine-specific demethylase 1).

Targets

LSD1 (lysine-specific demethylase 1)

Phase 2 pipeline (1)

• LCB01-0371 800mg, BID · LigaChem Biosciences, Inc. · Oncology
  LCB01-0371 is a selective inhibitor of lysine-specific demethylase 1 (LSD1) that restores gene expression silenced by aberrant histone methylation in cancer cells.

Patent intelligence

• lsd1 inhibitor patent landscape — aggregated cliff calendar, attackable patents, originator estates